Skip to content

Transcutaneous acupoint electrical stimulation improve depression after video-assisted thoracoscopic surgery: A randomized controlled study

Transcutaneous acupoint electrical stimulation improve depression after video-assisted thoracoscopic surgery: A randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000839
Enrollment
Unknown
Registered
2024-12-18
Start date
2024-12-20
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

video-assisted thoracoscopic surgery postoperative Depression

Interventions

Group T:Acupoint stimulation began 30 minutes before anesthesia induction and continued until the end of the operation
Group C:Sham-acupoint stimulation began 30 minutes before anesthesia induction , the Sham-acupoint was located 4cm inside the each acupoint, continued until the end of the operation

Sponsors

ChongQing University Fuling Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 18-65 Patients undergoing unilateral VATS surgery due to pulmonary nodules under general anesthesia ASA II-III stage The patient is conscious and normal, has no expression disorder, and is capable of cooperating with treatment and signing informed consent

Exclusion criteria

Exclusion criteria: Combined with acupoint local skin infection Patients with upper extremity nerve injury Patients with an implanted pacemaker Alcoholics and long-term users of opioids, hormones, anti-inflammatory and analgesic drugs Allergic to the drug used in the trial Have recently undergone TAES or acupoint therapy A history of mental illness or ongoing use of psychotropic drugs People being treated with monoamine oxidase (MAO) inhibitors Patients with severe diseases of heart, brain, liver, kidney and hematopoietic system Patients who were unable to cooperate with the study for any reason

Design outcomes

Primary

MeasureTime frame
Beck depression inventory score 30 days after surgery;

Secondary

MeasureTime frame
Sleep NRS score 2 days after surgery;Dosage of patient-controlled intravenous analgesia 48h after operation;Dosage of patient-controlled intravenous analgesia 24h after operation;Beck depression inventory score 2 days after surgery;Serum tumor necrosis factor-a concentration 2 days after surgery;Serum interleukin-6 concentration 2 days after surgery;24h postoperative resting pain score;48h postoperative moving pain score;48h postoperative resting pain score;TAES Related complications;24h postoperative moving pain score;

Countries

China

Contacts

Public ContactJunhua Zhang

Fuling Hospital Affiliated to Chongqing University

272073444@qq.com15213680591

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026